We have used a panel of well-characterized monoclonal antibodies (MoAbs) to examine the blood cells of a patient with a novel form of congenital dyserythropoietic anaemia (CDA) characterized by intra-erythroblastic and intraerythrocytic membranous inclusions. Twelve antibodies defining three nonoverlapping epitope groups on the extracellular domain of CD44 all failed to react with the red blood cells (RBCs) of the patient. A rabbit antibody to the cytoplasmic domain of CD44 from normal RBCs failed to react with the patient's RBC ghosts. In contrast, the patient's lymphocytes, granulocytes, and monocytes showed apparently normal CD44 expression. Bone marrow preparations stained with CD44 antibodies and visualized with '"l antimouse lg (F(ab)2) followed by autoradiography showed positive staining of lymphocytes and myeloid cells but not of most orthotolidine-positive erythroblasts. The patient's RBCs also gave weaker than normal reactions with MoAbs of anti-LWab specificity while MoAbs to glycophorins A, B, and C, Rh polypeptides, CD47, CD55, CD58, CD59, acetylcholinesterase, and Lutheran and Kell glycoproteins all gave normal reactions. Agglutination tests with human blood grouping sera demonstrated that the RBCs of D44 IS A WIDELY distributed cell surface glycoprotein that has been implicated in a diverse range of biologic functions including adhesion to components of the extracellular matrix,'.* lymphocyte homing3 tumor meta~tasis,~ T-cell a~tivation,~ and hematopoietic development.536 Recently, cDNA encoding the CD44 glycoprotein (CD44) has been cloned and ~e q u e n c e d~.~ and the existence of several different forms have been reported." All forms comprise a single polypeptide chain that traverses the plasma membrane once with the amino terminus in the extracellular domain. The extracellular domain comprises a distal disulphide bonded domain and a proximal domain rich in 0-glycans. The multiple forms of CD44 result from Cofa -b -) and that they also lack the high incidence RBC antigen AnWj. The phenotype In(a -b -) would be expected because these antigens are known to be expressed on CD44. There is also some evidence associating the AnWj antigen with CD44. However, the CO blood group locus is on chromosome 7p whereas that for CD44 is on chromosome 1 1 p. inserts occurring in the 0-glycan-rich domain that are presumed to result from alternative splicing ofexons." Certain monoclonal antibodies (MoAbs) in CD44 are capable of inhibiting the development of lymphoid and myeloid precursors when added to murine bone marrow (BM) cultures in vit1-0.~ These observations have lead to the suggestion that CD44 may play a role in the maturation of hematopoietic cells through interaction with extracellular matrix components and/or stromal cells in the marrow. In this report we describe our investigations on the hematopoietic cells of a child with a novel form of congenital dyserythropoietic anemia (CDA). The results show that the child has a gross deficiency of CD44 from her erythroid cells but not from her myeloid or lymphoid cells. It is known that the In" and Inb blood group antigens are located on erythrocyte CD44 glycoprotein" and consistent with this the patient's blood type was In(a-b-). Blood grouping tests further showed that the child has the very rare Co(a-b-) blood group phenotype and is negative for the high incidence antigen AnWj.
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MATERIALS AND METHODS
The clinical and hematologic features ofthe child with congenital anemia studied (case SF) have been reported elsewhere. ' Rabbit antiserum against CD44 glycoprotein. CD44 was isolated by immuno-affinity chromatography from normal human erythrocyte membranes prepared as described2' and solubilized in a minimum volume ofa Triton buffer (Sigma Ltd, Poole, UK) comprising 5% (wt/vol) Triton TX-100, 2 mmol/L phenylmethylsulphonylfluoride (PMSF), 0.5 mmol/L K2EDTA in phosphatebuffered saline (PBS), pH 7.3. This material was extracted using 6.6 mg CD44 antibody (BRIC 235) cross-linked to 1 mL of protein Asepharose gel (Bioprocessing Ltd, Consett, UK) as described.M The CD44 antibody column was saturated with a large volume (approximately 200 mL) of solubilized erythrocyte membranes and then washed extensively in a 1% (wt/vol) Triton buffer. CD44 was eluted with 50 mmol/L diethylamine, 2 mmol/L PMSF, 0.5% (wt/vol) sodium deoxycholate, pH 11.5. Fractions were adjusted to pH 8.0 with 2 mol/L glycine pH 2.0, dialyzed extensively against IO mmol/ L Tris/HCI pH 8.2 and then against water. The purified CD44 was dried by centrifugal evaporation. A rabbit was immunized with a subcutaneous injection of 50 pg CD44 in Freund's complete adjuvant followed 32 days later with a second subcutaneous injection of 50 pg of CD44 in Freund's incomplete adjuvant. The rabbit was bled IO days later, and serum was collected and heated at 56°C for 30 minutes. An aliquot of serum was extensively absorbed with normal, group A and group B, human erythrocytes until all agglutinating antibody was removed.
Immune precipitation studies. Immune precipitation was performed essentially as d e~r i b e d .~' Intact erythrocytes or unsealed erythrocyte membranes were incubated with an excess of MoAb or rabbit antiserum at 0°C. Immune complexes were recovered from solubilized erythrocyte membranes on protein A-sepharose.
Sodium dodecyl surfate-polyacrylamidegel electrophoresis (SDS-
) and Western blotting. Erythrocyte membranes were prepared as described2' and protein estimation was performed on each sample.32 SDS-PAGE and Western blotting were perfarmed as previously described33 except that polyvinylidone difluoride membrane (PVDF; Immobilon, Millipore Ltd, Milton Keynes, UK) was used and 5% (wt/vol) dried skimmed milk powder was used as a blocking agent.
Quantitation of erythrocyte CD44 binding sites. CD44 binding sites were estimated using 1251-labeled Fab fragments prepared from CD44 antibodies as previously described." Immunocytochemical analysis of BM samples. The presence of CD44 on hemoglobin-containing erythroblasts was investigated using cytospin preparations of BM cells from SF and a healthy subject by the procedure described by Wiener and Wi~kramasinghe.~~ After fixation in a phosphate-buffered mixture ofdistilled water, acetone, and formaldehyde, the cells were reacted with 50 p L of K Z -I or BRIC 235 supernatant for 30 minutes at room temperature, washed in PBS, and reincubated with 50 pL 1251-labeled antimouse Ig, F(ab), (0.06 pCi, 5 to 12 ng) (Amersham International, Aylesbury, UK). After further washes in PBS, the cells were fixed in methanol, stained for hemoglobin by reaction with o-tolidine, submitted to radioautography, and counterstained with Giemsa. Nucleated otolidine-positive (early and late polychromatic as well as orthochromatic erythroblasts) or negative cells (mainly myeloid cellsand lymphocytes) were scored for radioactivity under the light microscope. Flow cytometric analysis of SF's erythrocytes also showed a gross reduction in CD44 reactivity (Fig 1) and weak LWah reactivity (not shown). CD44 antibodies gave normal reactions with SF's lymphocytes (Fig l) , granulocytes, and monocytes (data not shown). The anti-LWah antibodies used did not react with normal lymphocytes, granulocytes, or monocytes.
RESULTS
Reactivity
Flow cytometry also revealed that SF blood samples contained a minor population of erythrocytes with normal expression of CD44. The sample taken on May 17, 199 1, 5 1 days after blood transfusion, contained a population of erythrocytes with normal expression of CD44 amounting to 28% of the total. The blood sample taken on September 10, 199 1, 167 days after blood transfusion, contained only 3% CD44-normal erythrocytes and the sample taken on June 15, 1992, 84 days after transfusion, contained 8% normal erythrocytes (data not shown). It is likely that the weak agglutination reactions obtained with CD44 antibodies on the samples taken on May 17, 199 1 and June 15, 1992 were caused by the presence of these CD44-normal cells and that these cells were transfused erythrocytes with normal CD44 reactivity. Erythrocytes from both the parents of SF and her unaffected sister gave normal reactions with all antibodies.
Reactivity of CD44 antibodies with BM cells. When normal and SF BM preparations were reacted with BRIC 235 or K Z -I CD44 antibodies and subsequently with 1251-antimouse Ig [F(ab)*], considerable radioactive labeling of myeloid cells and lymphocytes was found in normal as well as in SF BMs (>90%). By contrast, with both CD44 antibodies the percentage of radioactively labeled o-tolidine-positive erythroblasts was greatly decreased in SF, being 5% to 8% compared with 85% to 96% in the normal control. For common In and CO phenotypes and gave normal reactions with anti-LW and anti-AnWj sera (Fig 2) . Lacey et a135 describe an antibody made by a Co(a-b-) individual that gave weak reactions with other Co(a-b-) RBCs; this antibody gave normal-strength reactions with SF RBCs. Immtmohlotting analwis of erythrocyte membranes.from SFandher.fami1.v. When the electrophoretically separated components of erythrocyte membranes from SF were examined by immunoblotting with CD44 and LWab antibodies the reduced reactions observed in agglutination tests were confirmed (Fig 3, membranes prepared from the Sep tember IO, I99 I blood sample). Normal staining patterns were observed with Lutheran antibodies (Fig 3) and antibodies to erythrocyte band 3, CD58, and glycophorins A, B, C, and D (data not shown). Improved staining of CD44 in normal erythrocyte membranes was obtained by using a mixture containing equal volumes of antibodies against each of three CD44 epitopes. Weaker-than-normal staining was observed in SF erythrocyte membranes prepared from the May 17,199 1 (SFI) and June 15,1992 (SF3) blood samples and very weak staining was observed with membranes prepared from the September IO. 1991 (SF2) blood sample (Fig 3) . Antibodies to band 3 showed a slightly increased electrophoretic mobility when compared with control samples (data not shown). This increased mobility was also a p parent on Coomassie stained gels (Mr 107,000 for leading edge of SF band 3 compared with Mr 1 13,000 for control samples [data not shown]).
Reactivity of erythrocytes ,fvom
A rabbit antiserum was prepared to purified normal human erythrocyte CD44 and an aliquot was rendered specific for the cytoplasmic and/or transmembrane domain of the molecule by exhaustive absorption with intact normal erythrocytes. The rabbit antisera were used in immune precipitation experiments with normal, intact human erythrocytes and with unsealed erythrocyte membranes. The precipitated components were examined by immunoblotting with CD44 antibody KZ-I . The results are shown in Fig 4. Whole rabbit serum precipitated CD44 from intact erythrocytes (ie) and from unsealed membranes (um). Absorbed rabbit serum precipitated CD44 from unsealed erythrocyte membranes, where the cytoplasmic domain of CD44 was available for antibody binding, but not from intact human erythrocytes. Control serum, taken from the same rabbit before immunization, did not precipitate CD44.
In immunoblotting experiments markedly reduced binding of rabbit anti-CD44 and of absorbed rabbit anti-CD44 g h i j k l was observed with SF membranes compared with normal control membranes (Fig 4) . Antibodies in the rabbit antisera and also in the preimmune control serum bound to a component of Mr 70,000 which was present in SF erythrocyte membranes but not in control membranes (Fig 4) . This component was not found in membranes from the parents or sister of SF (not shown). The nature of this component is unknown.
Quantitation qf CD44 on erythrocytes.fiorn SF and her .fami!,? Purified radio-iodinated Fab fragments from murine monoclonal CD44 antibodies were used in quantitative binding assays to determine the level ofCD44 expression on the erythrocytes of SF and her family. The results (Table 1) show a gross reduction in CD44 levels on RBCs from SF but apparently normal levels of expression on both parents and the sister of SF. Fab fragments from antibodies to glycophorin A and glycophorin C were used as controls and these gave normal levels of binding to SF cells (Table 1) 
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Determinations were performed on SF erythrocytes from the blood sample taken on September 10, 1991. also normal with these cells. In tests with anti-LWab MoAbs some reduction in titration scores was observed with erythrocytes from patients SB (CDA I), DC (CDA 11), and CC (CDA unclassified). Tests with human blood group antibodies gave normal positive reactions with anti-Inb, anti-AnWj, and anti-COa.
DISCUSSION
Case was born in 1982 to haematologically normal, unrelated Danish parents. She had severe anemia, marked erythroblastosis and hyperbilirubinaemia at birth, and required regular blood transfusions during the first year of life. She now receives transfusions only when her hemoglobin, which is usually around 8.5 g/dL, decreases in association with common infections. The anemia is normochromic and normocytic and is caused by a combination of ineffectiveness of erythropoiesis and peripheral hemolysis. Hematologic features include a reticulocyte count of 2% to 15%, an HbF level of 40% (ie, higher than in other CDAs), a negative acidified serum lysis test (Ham's test), normoblastic erythroid hyperplasia, and nonspecific dysplastic features in several late erythroblasts-mainly basophilic stippling of the cytoplasm and marked irregularities in nuclear outline. Electron microscopy showed large distinctive intracytoplasmic inclusions consisting of compact masses of tubules and saccules within late erythroblasts, reticulocytes, and RBCs. The characteristic ultrastructural findings in CDA types I, 11, and 111 which are, respectively, a spongy appearance of abnormally electron-dense heterochromatin in a high proportion of erythroblasts, a double membrane running parallel to and 40 to 60 nm away from the erythroid cell membrane, and numerous giant mononucleate and multinucleate erythroblasts, were not observed. c-and ~-globin chains were present in some circulating RBCs. Studies of the globin genes showed that the patient had a normal KaalKaa-globin genotype and that her elevated HbF level was unlikely to be caused by mutations in the +globin gene cluster. The features of the CDA affecting case SF do not resemble those of CDA types I, 11, or 111 and this patient suffers from a novel type of CDA.
The results presented here provide clear evidence that the erythrocytes of SF have a gross deficiency of CD44 but that other peripheral blood cells (lymphocytes, granulocytes, monocytes) have normal expression of this cell surface glycoprotein. CD44 deficiency is also apparent in erythroid cells in SF's BM. Immunoblotting with a rabbit antiserum directed at the cytoplasmic (and transmembrane) domain of CD44 indicates that these domains are also deficient in SF erythrocytes. This result makes it unlikely that the lack of reactivity with MoAbs to the extracellular domain is caused by abnormal glycosylation rather than deficiency of the whole protein. The In" and Inb blood group antigens are camed on erythrocyte membrane CD44." Consistent with CD44 deficiency, SF RBCs typed as In(a-b-). It is well known that erythrocytes from Lu(a-b-) individuals of the dominant Zn(Lu) form of inheritance have an apparent deficiency of the Lutheran glycoproteins and CD44" and that these cells also lack the high incidence antigen AnWj as well as having weakened expression of other blood group antig e n~.~~ Therefore, Zn(Lu) type erythrocytes also type as In(a-b-). It was shown that SF has normal expression of erythrocyte Lutheran glycoproteins and therefore is not of the Zn(Lu) type. This is, to our knowledge, the first report of an individual with a selective, gross deficiency oferythrocyte CD44. Analysis of the erythrocytes of the parents and the unaffected sister of SF showed normal levels of CD44 and so we were unable to unequivocally establish inheritance; however, SF has been affected since birth and the defect would, therefore, appear to be recessively inherited. The unique nature of this case is further supported by our observations that CD44 deficiency is not a feature of RBCs obtained from several other patients with CDA that we have examined. In contrast, reduced expression of LW antigens is not uncommon in CDA patients and has also been seen, transiently, in autoimmune anemias3' SF RBCs were negative in the direct antiglobulin test, suggesting an absence of autoantibody.
The only other type of CDA which has so far yielded to analysis at the molecular level is CDA I1 (HEMPAS occur in one or other of the genes encoding enzymes involved in the N-glycosylation pathway and these defects result in plasma membrane abn~rrnalities.~~ In contrast, the primary abnormality in CDA I and CDA 111 is more likely to affect nuclear membranes or other nuclear constituents and gross abnormalities of the plasma membrane have not been r e~o r d e d .~' ,~~
In CDA I1 the abnormality in N-glycosylation of RBC membrane proteins is most readily detected by observing the increased electrophoretic mobility on SDS-PAGE of the major RBC glycoprotein band 3.14. 40 In the case of patient SF, a small shift in Mr ofband 3 was observed but this was not of the same order as that for CDA I1 (unpublished observations, October 199 I ).
The i blood group antigen is characteristically elevated in CDA I1 but other blood group antigens are not known to be markedly affected. There is a report of one patient having CDA I1 in association with the relatively rare Kell blood group phenotype K~( a + b -) ,~l but this blood group phenotype appeared to be unrelated to the di~ease.~' All the other CDA samples that we have examined have normal Ina/Inh and Coa/Cob phenotypes and normal expression of AnWj. The absence of Ina/Inb antigens from SF RBCs represents a unique phenotype that can be readily explained by deficiency of CD44 (discussed above). The AnWj antigen (formerly Anton) is known to be reduced on RBCs of Lu(a-b-) individuals of the dominant Zn(Lzc) type and to be inherited independently of the Lutheran Blood Group S y~t e m .~~-~~ The absence of the AnWj antigen from SF's RBCs raises the possibility that this determinant may be closely associated with erythrocyte CD44. The remarkable occurrence of a third very rare phenotype [Co(a-b-)l in SF RBCs seems unlikely to be a coincidence but is not easy to interpret because the biochemical nature of the membrane component expressing the Coa/Coh antigens is unknown. Nevertheless, the possibility that SF has inherited a silent CO allele from each parent and that this is independent from the CD44 deficiency cannot be formally ruled out (Fig 2) . The expression of the Colton antigens is unaffected by inheritance of the Zn(Lz1) gene. The Co(a-b-) phenotype has previously been described in four families. 35 One ofthese Co(a-b-) individu a l~~~ has been tested and found to have normal expression of the Inh antigen35 (and unpublished observations, August 1992). These results show that Ina/Inb expression is independent ofCoa/Coh expression in Lu(a-b-) RBCsofthe(ZnLu) type and in at least one of the previously described individuals with the Co(a-b-) phenotype. The Co(a-bp) phenotype has also been described in several Finnish patients who had monosomy 7.45,46 Evidence locating the locus for Colton blood groups to chromosome 7p has been presented rec e n t ]~.~' The CD44 gene is located on chromosome I 1 p1 3.4R Reciprocal translocations involving the short arms of chromosomes 7 and I 1 have been described in myeloid leukemia. 49 However, no evidence of chromosomal abnormalities was found on examination of BM aspirates from SF (N.I., unpublished, December 1987). Nevertheless, further studies of the expression of CD44 and the Colton blood group antigens on the erythrocytes ofpatients with chromosome 7 and/or chromosome 1 1 abnormalities might be rewarding.
The complete absence of CD44 from RBCs and most orthotolidine-positive erythroblasts, but not from myeloid or lymphoid cells, indicates a specific defect in either the erythroid CD44 gene or in control of its expression in erythroid cells. The concomitant occurrence ofthe Co(a-b-) phenotype suggests that the latter is more likely and such a conclusion would be consistent with the abnormal expression of hemoglobin genes in this patient reported by Tang et al." Erythroid CD44 cDNA has recently been cloned and sequenced from reticulocyte^.^' The derived amino acid sequence was identical to that reported for the hematopoietic isoform of CD44 from other cells. Harn et aI5' discuss the possibility that alternative processing of 3' untranslated regions of CD44 mRNA may regulate gene expression by modulating RNA stability or translational efficiency. Whether or not abnormalities at this level are responsible for the erythroid specific deficiency of CD44 in SF must await further study.
Clearly, the identification and characterization of the erythrocyte membrane component responsible for Colton blood groups would greatly facilitate attempts to establish the linkage, if any, between CD44 deficiency and the Co(a-b-) phenotype in this patient. The erythroid cells of SF also have novel intra-erythroblastic and intra-erythrocytic membraneous inclusionsi2 in addition to the two abnormalities in the erythrocyte plasma membrane described here, implying that there is a fundamental defect in membrane assembly of erythroid cells from this patient. An understanding of the defect(s) in erythropoiesis in patient SF may provide a useful approach to understanding the mechanism of membrane assembly and the regulation of differentiation in normal erythropoietic cells.
